
Andrew Wardlaw, Chief Ideas Officer
16 Nov, 2026 | 5 minutes
“Go on, it’s Christmas.” Four words that have sold an awful lot of chocolate! They work because everyone knows the bargain. You have another. The host feels generous. Let January deal with the consequences.
But what do you say to someone who already has what they wanted for Christmas? For many people approaching their first festive season on a GLP-1, that gift is control. And “go on” sounds rather different when you’re perfectly happy where you are.
To help us understand how GLP-1s are rewiring consumption, MMR polled 825 adults based in the U.K – although quite honestly, the participants could have been anywhere. To be eligible for the survey, participants must have started taking a prescribed GLP-1 medication this year. In other words – this will be their first ‘medicated’ Christmas.
Our thinking was that Christmas would represent a revealing reckoning on GLP-1 users’ eating and drinking attitudes and behaviors.
The headline result: 83% of GLP-1 users plan to buy less festive food and drink overall, but to choose better-quality items. And 40% agreed strongly. For an industry accustomed to selling a little extra at Christmas, that deserves a moment's thought.
There’s precious little in the findings to support the idea of a widespread festive holiday away from treatment. Some 58% expect to take the same dose over Christmas and 18% expect to take a higher one. We didn’t ask why, but our findings dispel any suggestions that users are looking forward to letting their guard down.
The results from this survey reveal that the greatest gift delivered by GLP-1s is the gift of control.
Intentions for the shopping basket are telling. Over half (53%) expect to buy smaller packs or portions, and 52% expect to buy fewer types of festive treat. The second figure is the more worrying one: a smaller pack size can accommodate a smaller appetite, but a shrinking repertoire means products must fight for a place in the basket at all.
One implication of GLP-1s that I am increasingly advising manufacturers about is the likely erosion of low-value reward - product experiences that command fairly low engagement – from mindless munches to sodas sipped on autopilot.
For manufacturers relying on absent minded consumption, these results reinforce the need to develop product experiences with greater meaning and emotional reward. It’s an area where MMR is particular active.
Then there’s the matter of what “better” actually tastes like. Previous findings by MMR research show that 45% of UK GLP-1 users and 56% of US users experience sweetness at a greater intensity. Users also report raised intensity across bitterness, sourness and saltiness. In addition, MMR’s sensory unit has found that for many GLP-1 consumers - flavor can quicky become overwhelming, certain textures can become cloying and carbonation can feels too aggressive. A richer recipe can make even a small treat hard to finish.
With so-called spillover effects of GLP-1s becoming increasingly evident, MMR’s survey results also shine a light on the likely dynamics around the Christmas table for many this year. Whilst 38% GLP-1 users worry they’ll be encouraged to carry on eating or drinking after they’ve had enough, 28% also predict that others around them could end up feeling obligated to reign it in a bit! As Boston Consulting Group said recently: GLP-1 effects do not end with the user.
Dickens allowed Scrooge a glimpse of a possible future and left him to decide what to do with it. Christmas offers our industry something similar. U.S self-pay prices have already fallen for some GLP-1 medicines, and researchers have tested an oral GLP-1 to help people maintain weight loss on an on-going basis after injectable treatment. As access widens and treatment extends into maintenance, more people could bring this sense of control to the weekly shop, long after the decorations come down.
So if your consumers are adopting a 'less but better' mindset, what does 'better' really mean when it has less to do with indulgence and more to do with predictability, tolerability and repeatability? Talk to the experts at MMR.